论文部分内容阅读
目的探讨胸腔镜肺癌根治术的安全性、有效性与可行性。方法回顾性分析2011年10月至2014年10月本院收治的胸腔镜手术微创组103例和随机抽取常规开放性肺癌根治术开胸组105例肺癌患者临床资料。比较2组患者的手术持续时间、术中出血量、清扫淋巴结总数、术后置管时间、住院天数、并发症发生率、住院费用、疼痛指标与术后7 d生活质量指标。结果腔镜组与开放组患者在手术持续时间、术中出血量、清扫淋巴结总数、并发症发生率与住院费用上差异无统计学意义(P>0.05),而在术后置管时间、住院天数与术后疼痛指标及术后7 d生活质量指标比较上差异有统计学意义(P<0.05)。结论胸腔镜肺癌手术安全、有效、可行,与传统手术相比优势明显。
Objective To investigate the safety, efficacy and feasibility of thoracoscopic lung cancer radical surgery. Methods The clinical data of 103 patients with minimally invasive thoracoscopic surgery in our hospital from October 2011 to October 2014 and 105 patients with lung cancer undergoing conventional open lung cancer radical thoracotomy were retrospectively analyzed. The duration of operation, blood loss, total lymph node dissection, postoperative catheterization, hospitalization days, complication rate, hospitalization cost, pain index and quality of life after 7 days were compared between the two groups. Results There was no significant difference in duration of operation, blood loss, total lymph node dissemination, incidence of complications and hospitalization costs between endoscopic group and open group (P> 0.05), but no difference was found in postoperative catheterization time, hospitalization There was significant difference between days and postoperative pain indexes and quality of life indexes after 7 days (P <0.05). Conclusions The operation of thoracoscope lung cancer is safe, effective and feasible. Compared with traditional surgery, the advantages are obvious.